RATING-SCALE FOR TARDIVE-DYSKINESIA

被引:407
作者
SIMPSON, GM
LEE, JH
ZOUBOK, B
GARDOS, G
机构
[1] ROCKLAND RES INST, ORANGEBURG, NY 10962 USA
[2] BOSTON STATE HOSP, BOSTON, MA 02124 USA
关键词
D O I
10.1007/BF00496058
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A rating scale for tardive dyskinesia was developed, consisting of nearly all signs seen by 2 groups of investigators over a 5 yr period. Some 34 items were included in the scale with a possibility of writing in idiosyncratic signs. The scale was shown to have good reliability and validity in studies carried out in humans. It is recommended as a suitable instrument for describing the breadth of tardive dyskinesia syndrome and also for quantifying the disorder. A 2nd scale, the abbreviated dyskinesia scale, contains 13 items which are more global than the items in the original scale. It was apparently both reliable and valid. Its use is suited to situations requiring less extensively detailed assessments. [Tardive dyskinesia is a side effect of psychotropic drug use.].
引用
收藏
页码:171 / 179
页数:9
相关论文
共 16 条
[1]  
COLE JO, IN PRESS
[2]  
CRANE GE, 1967, INT J NEUROPSYCH, V3, P286
[3]  
FAURBYE A, 1964, ACTA PSYCHIAT SCAND, V40, P1027
[4]   EVALUATION OF PAPAVERINE IN TARDIVE-DYSKINESIA [J].
GARDOS, G ;
COLE, JO ;
SNIFFIN, C .
JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (5-6) :304-310
[5]  
GARDOS G, 1977, ARCH GEN PSYCHIAT, V34, P1206
[6]  
GARDOS G, 1976, PSYCHOPHARMACOL BULL, V2, P7
[7]  
Schonecker M., 1957, Nervenartzt, V28, P35
[8]  
SIGWALD J, 1959, Rev Neurol (Paris), V100, P553
[9]  
SIGWALD J, 1959, Rev Neurol (Paris), V100, P751
[10]   DEANOL IN TREATMENT OF TARDIVE-DYSKINESIA [J].
SIMPSON, GM ;
VOITASHEVSKY, A ;
YOUNG, MA ;
LEE, JH .
PSYCHOPHARMACOLOGY, 1977, 52 (03) :257-261